Qing‐Qing Xing, Xuan Dong, Yan‐Dan Ren, Wei‐Ming Chen, Dan‐Yi Zeng, Yan‐Yan Cai, Mei‐Zhu Hong, Jin‐Shui Pan – 21 July 2020 – Although abnormal liver chemistries are linked to a higher risk of coronavirus disease 2019 (COVID‐19)–related death, liver manifestations may be diverse and even confusing. Thus, we performed a meta‐analysis of published liver manifestations and described the liver damage in patients with COVID‐19 who died or discharged alive.

Qing‐Qing Xing, Xuan Dong, Yan‐Dan Ren, Wei‐Ming Chen, Dan‐Yi Zeng, Yan‐Yan Cai, Mei‐Zhu Hong, Jin‐Shui Pan – 21 July 2020 – Although abnormal liver chemistries are linked to a higher risk of coronavirus disease 2019 (COVID‐19)–related death, liver manifestations may be diverse and even confusing. Thus, we performed a meta‐analysis of published liver manifestations and described the liver damage in patients with COVID‐19 who died or discharged alive.

Joud Arnouk, Vikrant P. Rachakonda, Diana Jaiyeola, Jaideep Behari – 21 July 2020 – Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. The prevalence of extreme obesity, defined as body mass index (BMI) of 50 kg/m2 or higher, is rising more rapidly than overall obesity. We aimed to compare the clinical outcomes and performance of noninvasive fibrosis assessment tools in NAFLD with or without extreme obesity.

John W. Ward – 21 July 2020

John W. Ward – 21 July 2020

David L. Thomas – 21 July 2020

Christoph Schultheiß, Donjete Simnica, Edith Willscher, Anna Oberle, Lorenzo Fanchi, Nicola Bonzanni, Nils H. Wildner, Julian Schulze Zur Wiesch, Christina Weiler‐Normann, Ansgar W. Lohse, Mascha Binder – 21 July 2020

Kathleen Cassel, Gregory Carlson – 21 July 2020

Lynn E. Taylor – 21 July 2020

Yu Du, Gauri Khandekar, Jessica Llewellyn, William J. Polacheck, Christopher S. Chen, Rebecca G. Wells – 21 July 2020